Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The National Institute for Health and Care Excellence (NICE) provides guidance on the use of GLP-1 receptor agonists in guideline NG28, recommending them for type 2 diabetes in specific contexts, such as when other therapies have proven inadequate, particularly in people with higher BMI or cardiovascular risk factors
That being said, every patient is an individual and its important that we use our clinical judgment to determine what the best treatment plan is for the patient. Eli Lilly and Company, the manufacturers of Mounjaro and Zepbound, funded this new research as well as the 2023 study
A medically guided approach focuses on understanding how your body regulates hunger, fullness, and metabolism over time
Women of reproductive age are particularly vulnerable
